Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2

BACKGROUND: Trastuzumab resistance in HER-2 positive breast cancer cells is closely related to overexpression of both epidermal growth factor receptor (EGFR) and human epidermal receptor (HER-2). SHP-1 has been demonstrated to downregulate tyrosine kinase activity including EGFR via its phosphatase...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yifen, Li, Rong, Zhang, Junyi, Wang, Gang, Liu, Bin, Huang, Xiaofang, Zhang, Tao, Luo, Rongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576899/
https://www.ncbi.nlm.nih.gov/pubmed/26396531
http://dx.doi.org/10.2147/OTT.S82225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576899/
https://www.ncbi.nlm.nih.gov/pubmed/26396531
http://dx.doi.org/10.2147/OTT.S82225

Ejemplares similares